SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
-3.68%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.12B
AUM Growth
+$1.12B
(-5.6%)
Cap. Flow
+$30.4M
Cap. Flow
% of AUM
2.7%
Top 10 Holdings %
Top 10 Hldgs %
66.5%
Holding
70
New
11
Increased
15
Reduced
11
Closed
12
Top Buys
| 1 |
Merck
MRK
|
$32.9M |
| 2 |
Novo Nordisk
NVO
|
$30.5M |
| 3 |
iRhythm Technologies
IRTC
|
$15.4M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$15.2M |
| 5 |
Sanofi
SNY
|
$14.1M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$21.9M |
| 2 |
Zoetis
ZTS
|
$20.1M |
| 3 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$18.3M |
| 4 |
Guardant Health
GH
|
$15.9M |
| 5 |
AstraZeneca
AZN
|
$15.7M |
Sector Composition
| 1 | Healthcare | 98.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sarepta Therapeutics
SRPT
$1.77B
| $9.84M | 0.82% |
131,245
+42,365
| +48% | +$3.18M |
|
27
Zentalis Pharmaceuticals
ZNTL
$124M
| $9.23M | 0.77% |
+328,397
| New | +$9.23M |
|
|
HZNP
28
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8M | 0.67% |
100,297
-132,597
| -57% | -$10.6M |
|
29
Syndax Pharmaceuticals
SNDX
$1.39B
| $7.95M | 0.66% |
413,428
-303,636
| -42% | -$5.84M |
|
|
OBSV
30
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $7.65M | 0.64% |
4,749,623
| – | – |
|
31
Adicet Bio
ACET
$61.1M
| $7.57M | 0.63% |
518,379
+102,090
| +25% | +$1.49M |
|
|
AKUS
32
DELISTED
Akouos, Inc. Common Stock
AKUS
| $7.11M | 0.59% |
1,515,074
| – | – |
|
|
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.28M | 0.52% |
653,047
-368,164
| -36% | -$3.54M |
|
34
argenx
ARGX
$43.2B
| $5.68M | 0.47% |
+15,000
| New | +$5.68M |
|
35
Bolt Biotherapeutics
BOLT
$9.56M
| $5.62M | 0.47% |
2,754,437
| – | – |
|
36
Travere Therapeutics
TVTX
$1.62B
| $5.15M | 0.43% |
212,593
-445,656
| -68% | -$10.8M |
|
|
IMGN
37
DELISTED
Immunogen Inc
IMGN
| $5.13M | 0.43% |
1,140,788
-287,381
| -20% | -$1.29M |
|
|
SGEN
38
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.94M | 0.41% |
+27,894
| New | +$4.94M |
|
|
KDNY
39
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.84M | 0.4% |
+276,609
| New | +$4.84M |
|
40
Xencor
XNCR
$610M
| $4.33M | 0.36% |
158,164
-115,828
| -42% | -$3.17M |
|
41
Geron
GERN
$938M
| $4.33M | 0.36% |
2,791,630
+886,868
| +47% | +$1.37M |
|
|
NCNA
42
NuCana
NCNA
$5.69M
| $4.06M | 0.34% |
5,599,999
| – | – |
|
|
GRTX
43
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $4.01M | 0.33% |
3,083,712
| – | – |
|
44
Amylyx Pharmaceuticals
AMLX
$890M
| $3.61M | 0.3% |
187,381
+87,381
| +87% | +$1.68M |
|
|
JNCE
45
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.98M | 0.25% |
981,928
-499,291
| -34% | -$1.51M |
|
|
AGEN
46
Agenus
AGEN
$133M
| $1.85M | 0.15% |
+952,742
| New | +$1.85M |
|
|
INBX
47
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.68M | 0.14% |
147,935
-366,705
| -71% | -$4.16M |
|
48
Celldex Therapeutics
CLDX
$1.46B
| $1.3M | 0.11% |
+48,304
| New | +$1.3M |
|
49
Synlogic
SYBX
$17.1M
| $661K | 0.06% |
574,972
| – | – |
|
50
PDS Biotechnology
PDSB
$58.3M
| $521K | 0.04% |
142,635
| – | – |
|